EDIT has been in the news 1500% more than usual
Feb 28, 2025, 1:31 PM
-30.60%
What does EDIT do
Editas Medicine, headquartered in Cambridge, Massachusetts, specializes in genome editing technology and developed a proprietary CRISPR-based platform for transformative genomic medicines. Its lead program, reni-cel, aims to treat sickle cell disease and beta thalassemia.
EDIT has been in the news recently: EDITAS Medicine is not mentioned in the provided information. The content focuses on Pacsun's launch of the Spring '25 RARE DNM Edit collection, which contributes 10% of sales to Selena Gomez's Rare Impact Fund, and Julien's Auctions' upcoming event featuring iconic celebrity fashion.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.